Table 2.
Cardiovascular parameters
| Imaging measurements | Total population | Men | Women |
| Diastolic function | |||
| E/A ratio | 1.3 (0.5) | 1.3 (0.5) | 1.4 (0.5) |
| E-DT(ms) | 182.7 (47.1) | 181.5 (48.4) | 183.7 (46.0) |
| Cardiac morphology | |||
| LV mass (g) | 99.5 (25.8) | 118.6 (22.2) | 82.9 (15.1) |
| LV mass index (g/m2) | 51.1 (10.2) | 57.0 (9.4) | 46.1 (7.9) |
| Cardiac haemodynamic | |||
| LV end-systolic volume, (ml) | 54.2 (16.5) | 61.5 (17.7) | 48.0 (12.2) |
| LV end-diastolic volume (ml) | 148.1 (32.8) | 165.6 (32.9) | 133.0 (24.1) |
| LV stroke volume (ml) | 93.9 (20.9) | 104.1 (21.6) | 85.0 (15.7) |
| LV ejection fraction (%) | 63.6 (5.9) | 63.1 (6.4) | 64.1 (5.4) |
| Cardiac output (l/min) | 6.2 (1.4) | 6.8 (1.4) | 5.6 (1.1) |
| Adiposity | |||
| VAT (cm2) | 88.3 (53.9) | 113.0 (55.4) | 66.9 (42.3) |
| SAT (cm2) | 235.3 (94.0) | 207.6 (73.3) | 259.4 (103.0) |
Results were weighted toward the BMI distribution of the general population. Data are presented as mean (SD) for continuous variables with a normal distribution.
E-DT, E-wave deceleration time; LV, left ventricle; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.